Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lötsch

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Der Anaesthesist|April 26, 2008
[Who likes placebo?]J Lötsch
Clinical Pharmacology and Therapeutics|May 21, 2010
Bedside-to-bench pharmacology: a complementary concept to translational pharmacologyJ Lötsch, G Geisslinger
British Journal of Anaesthesia|May 21, 2015
Morphine is not a prodrugA Dahan, J Lötsch
Clinical Pharmacokinetics|August 21, 2001
Morphine-6-glucuronide: an analgesic of the future?J Lötsch, G Geisslinger
The Pharmacogenomics Journal|January 18, 2006
Relevance of frequent mu-opioid receptor polymorphisms for opioid activity in healthy volunteersJ Lötsch, G Geisslinger
Schmerz (Berlin, Germany)|June 12, 2003
[Therapy with opioids in liver or renal failure]I Tegeder, G Geisslinger, J Lötsch
International Journal of Clinical Pharmacology and Therapeutics|February 6, 2004
Programming of a flexible computer simulation to visualize pharmacokinetic-pharmacodynamic modelsJ Lötsch, G Kobal, G Geisslinger
Schmerz (Berlin, Germany)|September 1, 2005
[Are polymorphisms in the mu-opioid receptor important for opioid therapy?]J Lötsch, R Freynhagen, G Geisslinger
Clinical Pharmacokinetics|August 19, 1999
Pharmacokinetics of opioids in liver diseaseI Tegeder, J Lötsch, G Geisslinger
European Journal of Pain (London, England)|January 1, 1997
The influence of stimulus duration on the reliability of pain ratings after nociceptive stimulation of the nasal mucosa with CO2J Lötsch, R Marchl, G Kobal
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Der Anaesthesist|April 26, 2008
[Who likes placebo?]J Lötsch
Clinical Pharmacology and Therapeutics|May 21, 2010
Bedside-to-bench pharmacology: a complementary concept to translational pharmacologyJ Lötsch, G Geisslinger
British Journal of Anaesthesia|May 21, 2015
Morphine is not a prodrugA Dahan, J Lötsch
Clinical Pharmacokinetics|August 21, 2001
Morphine-6-glucuronide: an analgesic of the future?J Lötsch, G Geisslinger
The Pharmacogenomics Journal|January 18, 2006
Relevance of frequent mu-opioid receptor polymorphisms for opioid activity in healthy volunteersJ Lötsch, G Geisslinger
Schmerz (Berlin, Germany)|June 12, 2003
[Therapy with opioids in liver or renal failure]I Tegeder, G Geisslinger, J Lötsch
International Journal of Clinical Pharmacology and Therapeutics|February 6, 2004
Programming of a flexible computer simulation to visualize pharmacokinetic-pharmacodynamic modelsJ Lötsch, G Kobal, G Geisslinger
Schmerz (Berlin, Germany)|September 1, 2005
[Are polymorphisms in the mu-opioid receptor important for opioid therapy?]J Lötsch, R Freynhagen, G Geisslinger
Clinical Pharmacokinetics|August 19, 1999
Pharmacokinetics of opioids in liver diseaseI Tegeder, J Lötsch, G Geisslinger
European Journal of Pain (London, England)|January 1, 1997
The influence of stimulus duration on the reliability of pain ratings after nociceptive stimulation of the nasal mucosa with CO2J Lötsch, R Marchl, G Kobal
Pageof 7